Post-storm resource center open through July 2 in downtown Bemidji
Jun. 29—BEMIDJI — A post-storm resource center will be open from 11 a.m. to 6 p.m. through Wednesday, July 2, at the former First National Bank building, 429 Minnesota Ave. NW.
The resource center, previously located at the Sanford Center, has been relocated to better assist residents impacted by the June 21 storm.
The center offers the following resources:
* Hot meals prepared by the Salvation Army. Lunch is served from 11:30 a.m. to 1:30 p.m., and dinner is served from 4 to 6 p.m.
* Cases of bottled water
* Individual snack items
* Pre-packaged hot meals
* Cleaning supplies
For those who lost food due to the storm or power outages, a Supplemental Nutrition Assistance Program (SNAP) and Minnesota Family Investment Program (MFIP) food benefit replacement program is available.
To learn more, visit the second floor of Beltrami County Health and Human Services at 616 America Ave. NW or call
(218) 333-8300.
The deadline to apply is Tuesday, July 1.
The resource center is supported by Beltrami County Public Health, the United Way of the Bemidji Area, American Red Cross, the Salvation Army, Community Resource Connections, the Bemidji Fire Department, as well as local and community donors.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News24
33 minutes ago
- News24
The natural cell-ution of aesthetics
We live in a world where everyone wants to be young forever and thanks to dedicated surgeons that is now possible through using your own stem cells. Stem cells harvesting can enhance your aesthetic while making it look natural. Stem cell therapy has gained immense popularity in recent years, with cosmetic surgery patients seeking options that offer more than traditional cosmetic enhancements. By utilising the body's own regenerative cells, cosmetic surgeons can achieve more natural-looking results, while also minimising recovery times and reducing the risk of complications. So, what is stem cell harvesting? Stem cell harvesting involves collecting stem cells, typically from adipose (fat) tissue, which can then be re-injected into the body to promote healing and rejuvenation. These cells have the remarkable ability to differentiate into various cell types, aiding in tissue repair and regeneration. As a result, patients undergoing procedures such as face lifts, liposuction and reconstruction/enhancement of buttocks, breasts and burns. Benefits of stem cell use in cosmetic surgery: Natural results: Stem cell therapy allows for more organic-looking enhancements, as the body recognises and integrates these cells. Accelerated healing: The regenerative properties of stem cells can significantly reduce downtime, allowing patients to return to their daily activities sooner. Minimise Scarring: Procedures utilising stem cells often results in less scarring compared to traditional methods. Versatile applications: From facial rejuvenation,hair restoration and body contouring, stem cells can be applied in various cosmetic procedures, providing versatile treatment options. Read more | 11 foods that may be making you struggle to lose weight 'The technology around stem cells is already changing the world of medicine, offering a better life for so many people around the world. That technology is also being incorporated into plastic surgery. It's without a doubt become a focal point for my team and I this year' says Dr Weyers. Dr Deon Weyers, South Africa's leader in plastic surgery, has recently begun this offering of cutting-edge stem cell harvesting techniques to his patients and is one of the first to do so in South Africa What are some of the advantages to stem cells in the world of plastic surgery? 'Benefits include their ability to transform into most cell types, thereby repairing damaged tissue. Because of this, researchers think they may have a role in treating a range of medical conditions. The growth factors, genetic messengers and tissue cells are good for all types of the skin but also injured tissue such as skin that is affected by aging, injury, cancer. These substances can help repair, rejuvenate and protect.'
Forbes
an hour ago
- Forbes
Spend $1, Get $3 Back From Washington: The Medicaid Funding Conundrum
Computer graphics of dollar banknotes stream flying around United States Capitol. Colorful twilight ... More sky with clouds in backgrounds. Finance, banking, monetary policy and quantitative easing concept. The great wave off Kanagawa homage to Hokusai. As the U.S. Senate deliberates the One Big Beautiful Bill, a key healthcare issue sparking debate is how to divide Medicaid costs, which serve low-income Americans, between state and federal taxpayers. Since 2014, Medicaid spending has surged 76%, reaching $872 billion in 2023—only 15% less than Medicare's budget, which serves seniors and Americans with disabilities. Medicaid's budget has grown faster than Medicare (66%), Social Security (60%), and the U.S. GDP (57%). Policymakers aiming to curb federal spending naturally focus on Medicaid. Medicaid costs are shared between the federal and state governments. One commonly used state funding practice—provider taxes—raises fiscal concerns for the federal government, according to the Government Accountability Office. Here's how it works: A state levies a provider tax on hospitals and other healthcare providers, based on revenue or other measures of size. It then claims this tax revenue (e.g., $1 billion) as its share of Medicaid funding and receives $3 billion in federal matching funds. The state returns most of the combined $4 billion to hospitals and uses the reminder for self-directed purposes related to Medicaid. It's a lucrative investment for hospitals—pay $1, get nearly $3 back. For states, it's an even better deal: a windfall of federal dollars with no real cost. But this game is rigged against federal taxpayers, who are left footing the bill. Worse still, both hospitals and states are now incentivized to expand provider taxes for bigger payoffs, further burdening federal taxpayers. The Government Accountability Office found that provider taxes drive a substantial and rapidly growing share of Medicaid spending, undermining accountability to federal taxpayers and limiting resources for patients in need. Moreover, as health policy expert Ann Kempski and I wrote in Health Affairs Forefront, this harms employers and workers. Directly, hospitals raise commercial prices to maximize Medicaid payments. Indirectly, large hospitals gain a competitive edge over smaller facilities and independent physicians, accelerating market consolidation and driving up commercial prices. States can achieve federal matching rates exceeding 12:1 for social needs, such as purchasing air conditioners for Medicaid beneficiaries. By offering such strong incentives, the federal government is effectively urging states to pursue these windfalls. It would be almost fiscally irresponsible for states not to do so. The root cause undermining Medicaid's program integrity is the separation between management and funding: federal taxpayers do not administer the program but generously foot the bill, giving states every incentive to overspend in order to receive even more. Various solutions have been proposed to address the Medicaid funding conundrum, including federalizing the program, delinking federal payments from state contributions, reducing matching rates, freezing provider taxes, and capping service payments. Solutions that tackle the root cause—the separation between management and funding—would generate greater federal savings but face stronger resistance due to their fiscal impact on states and providers, compared to those that merely treat the symptoms. Soon, we'll find out where the political winds in Washington settle.
Bloomberg
an hour ago
- Bloomberg
Moderna's Flu Vaccine Hits Goal, Paving Way for Combo Shot
By Updated on Save Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of selling combination vaccines. The shot's efficacy was 27% higher than a licensed influenza vaccine in adults 50 years and older, the company said in a statement Monday. The trial enrolled more than 40,000 adults across 11 countries.
